166 related articles for article (PubMed ID: 19576321)
1. Relation of severe coronary artery narrowing to insulin or thiazolidinedione use in patients with type 2 diabetes mellitus (from the Bypass Angioplasty Revascularization Investigation 2 Diabetes Study).
Pop-Busui R; Lombardero M; Lavis V; Forker A; Green J; Korytkowski M; Sobel BE; Jones TL;
Am J Cardiol; 2009 Jul; 104(1):52-8. PubMed ID: 19576321
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort.
Pop-Busui R; Lu J; Lopes N; Jones TL;
J Peripher Nerv Syst; 2009 Mar; 14(1):1-13. PubMed ID: 19335534
[TBL] [Abstract][Full Text] [Related]
3. Rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
Bach RG; Brooks MM; Lombardero M; Genuth S; Donner TW; Garber A; Kennedy L; Monrad ES; Pop-Busui R; Kelsey SF; Frye RL;
Circulation; 2013 Aug; 128(8):785-94. PubMed ID: 23857320
[TBL] [Abstract][Full Text] [Related]
4. Presentation in patients with angiographically documented coronary artery disease and type II diabetes mellitus (from the BARI 2D Clinical Trial).
Krishnaswami A; Hardison R; Nesto RW; Sobel B;
Am J Cardiol; 2012 Jan; 109(1):36-41. PubMed ID: 21958742
[TBL] [Abstract][Full Text] [Related]
5. Baseline characteristics of patients with diabetes and coronary artery disease enrolled in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
Bypass Angioplasty Revascularization Investigation 2 Diabetes Study Group
Am Heart J; 2008 Sep; 156(3):528-536, 536.e1-5. PubMed ID: 18760137
[TBL] [Abstract][Full Text] [Related]
6. Baseline coronary angiographic findings in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial (BARI 2D).
Schwartz L; Kip KE; Alderman E; Lu J; Bates ER; Srinivas V; Bach RG; Mighton LD; Feit F; King S; Frye RL;
Am J Cardiol; 2009 Mar; 103(5):632-8. PubMed ID: 19231325
[TBL] [Abstract][Full Text] [Related]
7. Sex differences in presentation and outcome among patients with type 2 diabetes and coronary artery disease treated with contemporary medical therapy with or without prompt revascularization: a report from the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation 2 Diabetes).
Tamis-Holland JE; Lu J; Korytkowski M; Magee M; Rogers WJ; Lopes N; Mighton L; Jacobs AK;
J Am Coll Cardiol; 2013 Apr; 61(17):1767-76. PubMed ID: 23500245
[TBL] [Abstract][Full Text] [Related]
8. Sex, clinical symptoms, and angiographic findings in patients with diabetes mellitus and coronary artery disease (from the Bypass Angioplasty Revascularization Investigation [BARI] 2 Diabetes trial).
Tamis-Holland JE; Lu J; Bittner V; Magee MF; Lopes N; Adler DS; Kip KE; Schwartz L; Groenewoud YA; Jacobs AK;
Am J Cardiol; 2011 Apr; 107(7):980-5. PubMed ID: 21276585
[TBL] [Abstract][Full Text] [Related]
9. Profibrinolytic, antithrombotic, and antiinflammatory effects of an insulin-sensitizing strategy in patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
Sobel BE; Hardison RM; Genuth S; Brooks MM; McBane RD; Schneider DJ; Pratley RE; Huber K; Wolk R; Krishnaswami A; Frye RL;
Circulation; 2011 Aug; 124(6):695-703. PubMed ID: 21768545
[TBL] [Abstract][Full Text] [Related]
10. The BARI 2D study: a randomised trial of therapies for type 2 diabetes and coronary artery disease.
Rutter MK; Nesto RW
Diab Vasc Dis Res; 2010 Jan; 7(1):69-72. PubMed ID: 20368235
[TBL] [Abstract][Full Text] [Related]
11. [Revascularization in patients with type 2 diabetes and coronary artery disease: BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) Study Group].
Störk S; Ertl G; Nitschmann S
Internist (Berl); 2010 May; 51(5):674-6. PubMed ID: 20352177
[No Abstract] [Full Text] [Related]
12. Factors related to the selection of surgical versus percutaneous revascularization in diabetic patients with multivessel coronary artery disease in the BARI 2D (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes) trial.
Kim LJ; King SB; Kent K; Brooks MM; Kip KE; Abbott JD; Jacobs AK; Rihal C; Hueb WA; Alderman E; Sing IR; Attubato MJ; Feit F;
JACC Cardiovasc Interv; 2009 May; 2(5):384-92. PubMed ID: 19463459
[TBL] [Abstract][Full Text] [Related]
13. BARI 2D: A Reanalysis Focusing on Cardiovascular Events.
Genuth SM; Vlachos H; Brooks MM; Bantle JP; Chaitman BR; Green J; Kelsey SF; King SB; McBane R; Sako EY; Schneider DJ; Steffes M; Frye RL;
Mayo Clin Proc; 2019 Nov; 94(11):2249-2262. PubMed ID: 31590967
[TBL] [Abstract][Full Text] [Related]
14. Response to letter regarding article, "rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial".
Bach RG; Brooks MM; Lombardero M; Genuth S; Donner TW; Garber A; Kennedy L; Monrad ES; Pop-Busui R; Kelsey SF; Frye RL;
Circulation; 2014 Apr; 129(16):e460-1. PubMed ID: 24753557
[No Abstract] [Full Text] [Related]
15. Increased Hazard of Myocardial Infarction With Insulin-Provision Therapy in Actively Smoking Patients With Diabetes Mellitus and Stable Ischemic Heart Disease: The BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) Trial.
Khan AA; Chung MJ; Novak E; Brown DL
J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28903941
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of insulin sensitization and insulin provision treatment strategies on concentrations of circulating adipokines in patients with diabetes and coronary artery disease in the BARI 2D trial.
Wolk R; Bertolet M; Brooks MM; Pratley RE; Sobel BE; Frye RL; Singh P; Calvin AD; Rutter MK; Mooradian AD; Somers VK;
Eur J Prev Cardiol; 2016 Jan; 23(1):50-8. PubMed ID: 25073857
[TBL] [Abstract][Full Text] [Related]
17. Rationale, design, and methods for glycemic control in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial.
Magee MF; Isley WL;
Am J Cardiol; 2006 Jun; 97(12A):20G-30G. PubMed ID: 16813735
[TBL] [Abstract][Full Text] [Related]
18. Economic outcomes of treatment strategies for type 2 diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.
Hlatky MA; Boothroyd DB; Melsop KA; Kennedy L; Rihal C; Rogers WJ; Venkitachalam L; Brooks MM;
Circulation; 2009 Dec; 120(25):2550-8. PubMed ID: 19920002
[TBL] [Abstract][Full Text] [Related]
19. The effect of age on clinical outcomes and health status BARI 2D (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes).
Chung SC; Hlatky MA; Faxon D; Ramanathan K; Adler D; Mooradian A; Rihal C; Stone RA; Bromberger JT; Kelsey SF; Brooks MM;
J Am Coll Cardiol; 2011 Aug; 58(8):810-9. PubMed ID: 21835316
[TBL] [Abstract][Full Text] [Related]
20. Different effects of thiazolidinediones on target vessel revascularization with bare metal stents: a meta-analysis.
Nishio K; Kobayashi Y
Cardiovasc Revasc Med; 2010; 11(4):227-31. PubMed ID: 20934654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
